BRIEF-Celator Pharmaceuticals says lesser healthcare resource use with vyxeostm

* Celator Pharmaceuticals announces positive results demonstrating reduced healthcare resource use with vyxeostm compared to standard treatment for acute myeloid leukemia (aml) Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)